2m 2m 2m 2m 2m 2m 2m
LB PHARM (LBRX)
NASDAQ
$40.06-$0.02 (-0.06%)
Price as of Aug 03, 2026 4:30 AM EDT- $1.1BMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
LB PHARM (LBRX)
$40.06-$0.02 (-0.06%)
LBRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $40.08 | ||
Change | -$0.82 (-2.00%) | ||
Open | $40.39 | ||
High | $40.67 | ||
Low | $38.98 | ||
Previous Close | $40.90 | ||
Volume | 338,247 | ||
30-Day Average Volume | 316,250 | ||
1-Week Change | 14.48% | ||
1-Month Change | 23.49% | ||
1-Year Change | N/A | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 28.7M | ||
Total Assets | $393.5M | ||
Market Cap | $1.1B | ||
Enterprise Value | $828.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$19.1M | ||
Free Cash Flow | -$23.3M | ||
EBIT | -$19.1M | ||
EBITDA | -$19.0M | ||
Net Working Capital | N/A | ||
EPS | -$0.67 | ||
Enterprise Value/EBITDA | -44 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -60 | ||
PEG | 6 | ||
Price/Free Cash Flow | -49 | ||
Price/Operating Cash Flow | -49 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue